Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Neurochemistry|September 1, 1994
Cerebrospinal fluid nitrite/nitrate levels in neurologic diseasesS Milstien, N Sakai, B J Brew, et al.
The Biochemical Journal|January 1, 1997
Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injuryK Saito, M Seishima, M P Heyes, et al.
Vaccine|August 1, 1995
Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study GroupB J Kuter, A Ngai, C M Patterson, et al.
Journal of Medical Virology|October 1, 1986
New findings in live, attenuated hepatitis A vaccine developmentP J Provost, R P Bishop, R J Gerety, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1983
Studies in chimpanzees of live, attenuated hepatitis A vaccine candidatesP J Provost, P A Conti, P A Giesa, et al.
Archives of General Psychiatry|June 1, 1992
Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeysJ D Higley, P T Mehlman, D M Taub, et al.
The Journal of Infectious Diseases|July 1, 1997
Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulinS M Lemon, P C Murphy, P J Provost, et al.
Bulletin of the Pan American Health Organization|January 1, 1977
Infectious hepatitis (hepatitis A) research in nonhuman primatesM R Hilleman, P J Provost, V M Villarejos, et al.
Brain Research|October 29, 1990
Sustained increases in cerebrospinal fluid quinolinic acid concentrations in rhesus macaques (Macaca mulatta) naturally infected with simian retrovirus type-DM P Heyes, M Gravell, W T London, et al.
Journal of Hepatology|January 1, 1993
Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326FM E Armstrong, P A Giesa, J P Davide, et al.
Pageof 6